![]()
businesswire | VBI Vaccines and Brii Biosciences Expand Hepatitis B Partnership To Address Both Prevention and Treatment in License and Collaboration Agreements for up to $437 Million Plus Royalties |
businesswire | VBI Vaccines Announces Results of Annual General Meeting |
yahoo | VBI Vaccines Reports Full Year 2022 Financial Results |
yahoo | What Type Of Shareholders Own The Most Number of VBI Vaccines Inc. Shares? |
yahoo | VBI Vaccines Announces New Long-Term Follow-Up Clinical Data for its 3-Antigen Adult Hepatitis B Vaccine Presented at EASL 2022 - Yahoo Finance |
yahoo | Is VBI Vaccines Weighed On By Its Debt Load? |
marketscreener | VBI Vaccines Announces European Commission Marketing Authorisation for PreHevbri™, a 3-Antigen Adult Hepatitis B Vaccine |
yahoo | VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2021, Provides Corporate Update and Outlook for 2022 - Yahoo Finance |
markets.businessinsider | QualTek Names New Independent Board Appointees to its Board of Directors |
yahoo | VBI Vaccines Receives Positive CHMP Opinion for 3-Antigen Hepatitis B Vaccine for Immunization Against Hepatitis B Infection in Adults in the European Union - Yahoo Finance |
businesswire | VBI Vaccines Announces PreHevbrio™ [Hepatitis B Vaccine ] Recommended by CDC Advisory Committee on Immunization Practices for the Prevention of Hepatitis B in Adults |
yahoo | VBI Vaccines to Participate in the B. Riley Securities 2022 Oncology Investor Conference |
marketscreener | VBI Vaccines Announces Dosing of First Patient in Second Phase 2 Study in Chronic Hepatitis B Patients as Part of Expansion of Clinical Collaboration With Brii Bio |
seekingalpha | VBI Vaccines Announces Filing of New Drug Submission for 3-Antigen Hepatitis B Vaccine to Health Canada |
marketscreener | VBI Vaccines to Present New Overall Survival Data from Phase 2a Study in Recurrent GBM at the World Vaccine & Immunotherapy Congress 2021 |
businesswire | VBI Vaccines to Participate in Jefferies London Healthcare Conference |
yahoo | VBI Vaccines Announces Third Quarter 2021 Financial Results and Provides Corporate Update |
businesswire | VBI Vaccines Announces e-Poster Presentation of 3-Antigen Prophylactic Hepatitis B Vaccine Data at The Liver Meeting® 2021 |
